Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Spectral Evaluation of Eyeglass Blocking Efficiency of Ultraviolet/High-energy Visible Blue Light for Ocular Protection.

Giannos SA, Kraft ER, Lyons LJ, Gupta PK.

Optom Vis Sci. 2019 Jul;96(7):513-522. doi: 10.1097/OPX.0000000000001393.

PMID:
31274740
2.

Photokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera.

Giannos SA, Kraft ER, Zhao ZY, Merkley KH, Cai J.

Pharm Res. 2018 Mar 29;35(6):110. doi: 10.1007/s11095-018-2392-7.

3.

Formulation Stabilization and Disaggregation of Bevacizumab, Ranibizumab and Aflibercept in Dilute Solutions.

Giannos SA, Kraft ER, Zhao ZY, Merkley KH, Cai J.

Pharm Res. 2018 Feb 28;35(4):78. doi: 10.1007/s11095-018-2368-7.

4.

Identifying present challenges to reliable future transdermal drug delivery products.

Giannos SA.

Ther Deliv. 2015;6(9):1033-41. doi: 10.4155/tde.15.62. Epub 2015 Sep 30. Review.

PMID:
26419262
5.

Photokinetic Drug Delivery: Light-Enhanced Permeation in an In Vitro Eye Model.

Godley BF, Kraft ER, Giannos SA, Zhao ZY, Haag AM, Wen JW.

J Ocul Pharmacol Ther. 2015 Dec;31(10):650-7. doi: 10.1089/jop.2015.0005. Epub 2015 Aug 27.

PMID:
26313292

Supplemental Content

Loading ...
Support Center